Author

Danijela Kurija

Medical University of Vienna

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Aleksandr BykoviD· 1 shared Barbara Sax· 1 shared Branka Radic-SarikasiD· 1 shared Florian HalbritteriD· 1 shared Gerhard Weber· 1 shared Heinrich KovariD· 1 shared Lukas KenneriD· 1 shared Maximilian O. Kauer· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aleksandr BykovORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

YAP1 is a key regulator of EWS::FLI1-dependent malignant transformation upon IGF-1 mediated reprogramming of bone mesenchymal stem cells

Rahil Noorizadeh, Barbara Sax, Tahereh Javaheri, Branka Radic-Sarikas, Valerie Fock, Veveeyan Suresh, Maximilian O. Kauer, Aleksandr Bykov, Danijela Kurija, Michaela Schlederer, Lukas Kenner, Gerhard Weber, Wolfgang Mikulits, Florian Halbritter, Richard Moriggl, Heinrich Kovar

The paper shows that IGF-1 reprograms bone mesenchymal stem cells in EWS::FLI1-mutant mice, leading to tumor formation, with Yap1 playing a central role, and suggests combined IGF-1R and YAP/TEAD inhibition as a potential treatment.

Cell Reports · Mar 1, 2025Peer-reviewedCancer Biology